Aplastic anemia classification: Difference between revisions
m (Robot: Automated text replacement (-msbeih@perfuse.org +msbeih@wikidoc.org, -psingh@perfuse.org +psingh13579@gmail.com, -agovi@perfuse.org +agovi@wikidoc.org, -rgudetti@perfuse.org +ravitheja.g@gmail.com, -lbiller@perfuse.org +lbiller@wikidoc.org,...) |
No edit summary |
||
(11 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Aplastic anemia}} | {{Aplastic anemia}} | ||
{{CMG}}; '''Associate Editor(s)-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.D.]] [mailto:psingh13579@gmail.com] {{N.F}} | |||
==Overview== | |||
Aplastic anemia may be classified according to blood cell counts into 3 subgroups, moderately severe aplastic anemia or non severe AA (nSAA), severe aplastic anemia (SAA), and very severe aplastic anemia(vSAA). | |||
{{ | ==Classification== | ||
== | Aplastic anemia may be classified according to blood cell counts into 3 subgroups:<ref name="pmid24424170">{{cite journal |vauthors=Dolberg OJ, Levy Y |title=Idiopathic aplastic anemia: diagnosis and classification |journal=Autoimmun Rev |volume=13 |issue=4-5 |pages=569–73 |date=2014 |pmid=24424170 |doi=10.1016/j.autrev.2014.01.014 |url=}}</ref> | ||
[[ | * Moderately severe aplastic anemia or non severe AA (nSAA) | ||
* Severe aplastic anemia (SAA) | |||
* Very severe aplastic anemia(vSAA) | |||
{| class="wikitable" | |||
|+ '''Classification of aplastic anemia (two out of three criteria must be met)''' | |||
!style="background: #4479BA; color: #FFFFFF; " | | |||
!style="background: #4479BA; color: #FFFFFF; " |nSAA | |||
!style="background: #4479BA; color: #FFFFFF; " |SAA | |||
!style="background: #4479BA; color: #FFFFFF; " |vSAA | |||
|- | |||
| style="background: #DCDCDC; text-align: center;" |[[Reticulocytes]] | |||
| style="background: #F5F5F5; text-align: center;" |<20G/L | |||
| style="background: #F5F5F5; text-align: center;" |<20G/L | |||
| style="background: #F5F5F5; text-align: center;" |<20G/L | |||
|- | |||
| style="background: #DCDCDC; text-align: center;" |[[Platelet|Platelets]] | |||
| style="background: #F5F5F5; text-align: center;" |<50 G / L | |||
| style="background: #F5F5F5; text-align: center;" |<20G/L | |||
| style="background: #F5F5F5; text-align: center;" |<20G/L | |||
|- | |||
| style="background: #DCDCDC; text-align: center;" |[[Granulocytes|Neutrophilic granulocytes]] | |||
| style="background: #F5F5F5; text-align: center;" |<1.0 G / L | |||
| style="background: #F5F5F5; text-align: center;" |<0.5G/L | |||
| style="background: #F5F5F5; text-align: center;" |0.2G/L | |||
|} | |||
This classification is of prognostic relevance and has an influence on therapeutic procedures. | |||
==Classification== | ==Classification based on the presumed etiology== | ||
=== | {| class="wikitable" | ||
=== | |+Classification based on the presumed etiology | ||
|- | |||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; " |''Acquired aplastic anemia'' | |||
| style="background: #DCDCDC; text-align: center;" |[[Idiopathic]] | |||
| style="background: #F5F5F5; text-align: center;" | | |||
|- | |||
| style="background: #DCDCDC; text-align: center;" |Secondary | |||
| style="background: #F5F5F5; text-align: left;" | | |||
* [[Irradiation]] | |||
* Drugs and chemicals: cytotoxic agents, [[benzene]], chloromphenicol, [[gold]] | |||
salts, [[Non-steroidal anti-inflammatory drug|NSAIDS]]. | |||
* [[Idiosyncratic drug reaction|Idiosyncratic]] reactions | |||
* Viruses: [[Epstein Barr virus]], [[parvovirus B19]], [[Human Immunodeficiency Virus (HIV)|HIV]] | |||
* Immune diseases | |||
* [[Pregnancy]] | |||
* [[PNH]] [[Paroxysmal nocturnal hemoglobinuria]] | |||
|- | |||
| colspan="2" style="background: #4479BA; color: #FFFFFF; " |'''''Inherited aplastic anemia''''' | |||
| style="background: #F5F5F5; text-align: left;" | | |||
* [[Fanconi anemia]] | |||
* [[Dyskeratosis congenita|Dyskeratosis congenita]] | |||
* [[Amegakaryocytic thrombocytopenia]] | |||
* [[Shwachman-Diamond syndrome]] | |||
|} | |||
==References== | ==References== |
Latest revision as of 18:55, 29 October 2018
Aplastic anemia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Aplastic anemia classification On the Web |
American Roentgen Ray Society Images of Aplastic anemia classification |
Risk calculators and risk factors for Aplastic anemia classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.D. [2] Nazia Fuad M.D.
Overview
Aplastic anemia may be classified according to blood cell counts into 3 subgroups, moderately severe aplastic anemia or non severe AA (nSAA), severe aplastic anemia (SAA), and very severe aplastic anemia(vSAA).
Classification
Aplastic anemia may be classified according to blood cell counts into 3 subgroups:[1]
- Moderately severe aplastic anemia or non severe AA (nSAA)
- Severe aplastic anemia (SAA)
- Very severe aplastic anemia(vSAA)
nSAA | SAA | vSAA | |
---|---|---|---|
Reticulocytes | <20G/L | <20G/L | <20G/L |
Platelets | <50 G / L | <20G/L | <20G/L |
Neutrophilic granulocytes | <1.0 G / L | <0.5G/L | 0.2G/L |
This classification is of prognostic relevance and has an influence on therapeutic procedures.
Classification based on the presumed etiology
Acquired aplastic anemia | Idiopathic | |
---|---|---|
Secondary |
salts, NSAIDS.
| |
Inherited aplastic anemia |
References
- ↑ Dolberg OJ, Levy Y (2014). "Idiopathic aplastic anemia: diagnosis and classification". Autoimmun Rev. 13 (4–5): 569–73. doi:10.1016/j.autrev.2014.01.014. PMID 24424170.